The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...
Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.
Laura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.
Is the COVID-19 vaccine safe and effective for infants and young children? Here's what parents need to know about vaccinating their babies and toddlers against COVID-19.
With the emergence of the Omicron variant contracting or spreading COVID-19 in November 2021, Moderna and other vaccine companies developed boosters, which Moderna included in another phase of its ...
The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...
The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.
The COVID-19 strain that is dominating in Canada this winter season is K.P3, a sub-lineage of the omicron strain ... on California duck farm Sick of the stomach bug? Moderna is making a norovirus ...
HHS said Moderna will develop and assess an mRNA vaccine against H7N9 avian influenza in a phase ... limited real-world data has been gathered in the post-Omicron era on Paxlovid efficacy. In this ...
The coprimary endpoints of GMRs of nAbs against RSV-A (0.80; 95% CI, 0.70-0.90), SARS-CoV-2 ancestral strain (0.96; 95% CI, 0.87-1.06), and Omicron ... vaccines across various population groups are ...
1 Omicron SARS-CoV-2 virus. These results show that the KP.2 vaccine offers adequate protection against ... Seqirus, Pfizer, and Moderna. Emory University receives funds for NR to conduct research ...
On one of the final days of the Biden Administration, the US Department of Health and Human Services (HHS) announced $590 million in support for Moderna to speed the development of mRNA vaccines ...